Navigation Links
BU wins $1.6M NIH grant to target protein-protein interactions

(Boston) An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.

Only about 10% of the potential drug targets in the human genome have been successfully targeted with marketed drugs. Of the remaining 90%, a large proportion are intracellular proteins whose function is critically dependent on their reversible interactions with other proteins. Despite decades of effort by the pharmaceutical industry, it has proven extraordinarily difficult to develop oral drugs that inhibit PPI.

The work will determine if appropriately designed synthetic macrocycles can inhibit PPI targets while maintaining good drug-like properties. The test system is the intracellular PPI target NFB essential modulator (NEMO), a component of the Inhibitor of B kinase (IKK) complex. Chronic hyperactivity of the NFB pathway is found in human inflammatory diseases and cancers. Inhibiting the interaction of NEMO with IKK, as a more targeted alternative to completely ablating all IKK kinase activity, represents a promising new approach for attenuating inflammation.

Led by College of Arts & Sciences Professor Adrian Whitty (quantitative biochemistry and drug discovery), the multidisciplinary research team includes Profs. Sandor Vajda and Dima Kozakov (computational chemistry), John Porco and Aaron Beeler (macrocycle design and synthesis), Karen Allen (X-ray crystallography), and Tom Gilmore (NF-B pathway biology). Their grant is funded by the NIH's National Institute of General Medical Sciences.


Contact: Patrick Farrell
Boston University Medical Center

Page: 1

Related biology news :

1. Exciting new companies at NJITs small biz incubator get 100K in grants
2. Broad Institute awarded major grant to bolster epigenomics research
3. Entertainment Software Association Foundation awards grant to FAS for immune attack
4. National Science Foundation grants Clemson professors award to develop nanoprobes
5. Dunn Foundation gives Rice $3M for collaborative research grants
6. National Science Foundation grant expands UMCES oyster research
7. Penn State receives new NASA astrobiology grant
8. BIO-key(R) Granted Additional Patent for Biometric Security Solution
9. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
10. Northwest climate change is target of $3.2M in grants to University of Oregon
11. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
Post Your Comments:
(Date:5/23/2017)... GENOA, Italy , May 23, 2017  Hunova, the first robotic ... and trunk, has been officially launched in Genoa, Italy ... Europe and the USA . The ... launched on the market by the IIT spin-off Movendo Technology thanks to ... view the Multimedia News Release, please click: ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology: